A Randomized, Double Blind, Trial of Metformin and Atorvastatin in Delaying Androgen Deprivation Therapy Among Men With Rising PSA Following Radical Prostatectomy or Radiotherapy: The LIGAND (LIpitor and biGuanide to Androgen Delay) Trial
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Atorvastatin (Primary) ; Metformin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms LIGAND
- 13 Feb 2018 Planned End Date changed from 1 Jul 2020 to 1 Dec 2022.
- 13 Feb 2018 Planned primary completion date changed from 1 Jul 2020 to 1 Dec 2021.
- 13 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Jan 2019.